Brief: Stoke Therapeutics reports Q2 results

Stoke Therapeutics

08/08/2022 12:20

Aug 8 (Reuters) - Stoke Therapeutics Inc  STOK.O :
    * STOKE THERAPEUTICS REPORTS SECOND QUARTER FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATES
    * Q2 LOSS PER SHARE $0.63
    * AS OF JUNE 30, 2022,  HAD $276.2 MILLION IN CASH,
EQUIVALENTS,
ANTICIPATED TO FUND OPERATIONS INTO 2025

Source text for Eikon:  ID:nBw2k4FkJa 
Further company coverage:  STOK.O 

 (Reporting by Priyamvada C)
 ((Priyamvada.C@thomsonreuters.com;))